The new guidelines encourage patients to reduce or eliminate alcohol consumption entirely compared with the old guidelines.

Pending the European Commission’s final decision, nipocalimab could be the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK ...

Kallo said Tesla is increasingly being valued as a physical AI company rather than a traditional carmaker. While recent ...

Learn the significance of rolling returns, how they help analyze investment performance, and their role in smoothing data ...